Melanocytes, located at the base of the follicle, synthesize melanin
Simultaneously, it slows stomach emptying, helping you feel full longer
More recently, innovative molecules like the dual glucose-dependent insulinotropic polypeptide and the glucagon-like peptide 1 (GLP1R-GIPR) receptors agonists, such as tirzepatide, have shown even greater efficacy, with weight loss up to 18% [21]
Practical tip A combination of SGLT2i and GLP-1RA might theoretically improve cardiorenal benefits in patients with T2D and either ASCVD or multiple risk factors for ASCVD whose A1c remains suboptimal despite initial treatment with only one of these agents or if clinical status changes (e.g., new onset HF or CKD
Theres an option like a superhero for your skin
Chronic fatigue suggests something in your protocol needs adjustment